Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk

David M. Euhus, Leslie Cler, Narayan Shivapurkar, Sara Milchgrub, George N. Peters, A. Marilyn Leitch, Shashank Heda, Adi F. Gazdar

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The multistage model of breast carcinogenesis suggests that errors in DNA replication and repair generate diversity in the breast epithelium (the mutator phenotype), resulting in selection and expansion of premalignant clones with an acquired survival advantage. We measured loss of heterozygosity (LOH) in breast epithelial cells obtained by random fine-needle aspiration (FNA) biopsy from 30 asymptomatic women whose risk of breast cancer had been defined by the Gail model. Polymorphic microsatellite markers were selected on the basis of their relevance to breast cancer. Breast epithelium of 11 (37%) of 30 women had normal cytology, and that of 19 (63%) had proliferative cytology (eight with atypia and 11 without atypia). LOH was detected in two women with normal cytology and in 14 women (seven with atypia and seven without atypia) with proliferative cytology (P = .007). The frequency of LOH was associated with the cytological diagnosis, as well. The mean proportion (range) of informative markers demonstrating LOH was 0.02 (0-0.20) for the 11 women with normal cytology, as compared with 0.15 (0-0.50) for the 19 women with proliferative cytology (P = .02). Mean lifetime risk for developing breast cancer, as calculated by the Gail model, was 16.7% for women with no LOH compared with 22.9% for women with any LOH (P = .05). These observations support a multistage model of breast carcinogenesis where the initiating events are those that result in genomic instability. Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA.

Original languageEnglish (US)
Pages (from-to)858-860
Number of pages3
JournalJournal of the National Cancer Institute
Volume94
Issue number11
StatePublished - Jun 5 2002

Fingerprint

Loss of Heterozygosity
Breast
Epithelium
Breast Neoplasms
Cell Biology
Fine Needle Biopsy
Carcinogenesis
Epithelial Cells
Genomic Instability
DNA Replication
DNA Repair
Microsatellite Repeats
Clone Cells
Phenotype
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk. / Euhus, David M.; Cler, Leslie; Shivapurkar, Narayan; Milchgrub, Sara; Peters, George N.; Leitch, A. Marilyn; Heda, Shashank; Gazdar, Adi F.

In: Journal of the National Cancer Institute, Vol. 94, No. 11, 05.06.2002, p. 858-860.

Research output: Contribution to journalArticle

Euhus, David M. ; Cler, Leslie ; Shivapurkar, Narayan ; Milchgrub, Sara ; Peters, George N. ; Leitch, A. Marilyn ; Heda, Shashank ; Gazdar, Adi F. / Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk. In: Journal of the National Cancer Institute. 2002 ; Vol. 94, No. 11. pp. 858-860.
@article{2b6f483388c54963b72a1a9d2d214c80,
title = "Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk",
abstract = "The multistage model of breast carcinogenesis suggests that errors in DNA replication and repair generate diversity in the breast epithelium (the mutator phenotype), resulting in selection and expansion of premalignant clones with an acquired survival advantage. We measured loss of heterozygosity (LOH) in breast epithelial cells obtained by random fine-needle aspiration (FNA) biopsy from 30 asymptomatic women whose risk of breast cancer had been defined by the Gail model. Polymorphic microsatellite markers were selected on the basis of their relevance to breast cancer. Breast epithelium of 11 (37{\%}) of 30 women had normal cytology, and that of 19 (63{\%}) had proliferative cytology (eight with atypia and 11 without atypia). LOH was detected in two women with normal cytology and in 14 women (seven with atypia and seven without atypia) with proliferative cytology (P = .007). The frequency of LOH was associated with the cytological diagnosis, as well. The mean proportion (range) of informative markers demonstrating LOH was 0.02 (0-0.20) for the 11 women with normal cytology, as compared with 0.15 (0-0.50) for the 19 women with proliferative cytology (P = .02). Mean lifetime risk for developing breast cancer, as calculated by the Gail model, was 16.7{\%} for women with no LOH compared with 22.9{\%} for women with any LOH (P = .05). These observations support a multistage model of breast carcinogenesis where the initiating events are those that result in genomic instability. Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA.",
author = "Euhus, {David M.} and Leslie Cler and Narayan Shivapurkar and Sara Milchgrub and Peters, {George N.} and Leitch, {A. Marilyn} and Shashank Heda and Gazdar, {Adi F.}",
year = "2002",
month = "6",
day = "5",
language = "English (US)",
volume = "94",
pages = "858--860",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Loss of Heterozygosity in benign breast epithelium in relation to breast cancer risk

AU - Euhus, David M.

AU - Cler, Leslie

AU - Shivapurkar, Narayan

AU - Milchgrub, Sara

AU - Peters, George N.

AU - Leitch, A. Marilyn

AU - Heda, Shashank

AU - Gazdar, Adi F.

PY - 2002/6/5

Y1 - 2002/6/5

N2 - The multistage model of breast carcinogenesis suggests that errors in DNA replication and repair generate diversity in the breast epithelium (the mutator phenotype), resulting in selection and expansion of premalignant clones with an acquired survival advantage. We measured loss of heterozygosity (LOH) in breast epithelial cells obtained by random fine-needle aspiration (FNA) biopsy from 30 asymptomatic women whose risk of breast cancer had been defined by the Gail model. Polymorphic microsatellite markers were selected on the basis of their relevance to breast cancer. Breast epithelium of 11 (37%) of 30 women had normal cytology, and that of 19 (63%) had proliferative cytology (eight with atypia and 11 without atypia). LOH was detected in two women with normal cytology and in 14 women (seven with atypia and seven without atypia) with proliferative cytology (P = .007). The frequency of LOH was associated with the cytological diagnosis, as well. The mean proportion (range) of informative markers demonstrating LOH was 0.02 (0-0.20) for the 11 women with normal cytology, as compared with 0.15 (0-0.50) for the 19 women with proliferative cytology (P = .02). Mean lifetime risk for developing breast cancer, as calculated by the Gail model, was 16.7% for women with no LOH compared with 22.9% for women with any LOH (P = .05). These observations support a multistage model of breast carcinogenesis where the initiating events are those that result in genomic instability. Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA.

AB - The multistage model of breast carcinogenesis suggests that errors in DNA replication and repair generate diversity in the breast epithelium (the mutator phenotype), resulting in selection and expansion of premalignant clones with an acquired survival advantage. We measured loss of heterozygosity (LOH) in breast epithelial cells obtained by random fine-needle aspiration (FNA) biopsy from 30 asymptomatic women whose risk of breast cancer had been defined by the Gail model. Polymorphic microsatellite markers were selected on the basis of their relevance to breast cancer. Breast epithelium of 11 (37%) of 30 women had normal cytology, and that of 19 (63%) had proliferative cytology (eight with atypia and 11 without atypia). LOH was detected in two women with normal cytology and in 14 women (seven with atypia and seven without atypia) with proliferative cytology (P = .007). The frequency of LOH was associated with the cytological diagnosis, as well. The mean proportion (range) of informative markers demonstrating LOH was 0.02 (0-0.20) for the 11 women with normal cytology, as compared with 0.15 (0-0.50) for the 19 women with proliferative cytology (P = .02). Mean lifetime risk for developing breast cancer, as calculated by the Gail model, was 16.7% for women with no LOH compared with 22.9% for women with any LOH (P = .05). These observations support a multistage model of breast carcinogenesis where the initiating events are those that result in genomic instability. Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA.

UR - http://www.scopus.com/inward/record.url?scp=0037024480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037024480&partnerID=8YFLogxK

M3 - Article

C2 - 12048275

AN - SCOPUS:0037024480

VL - 94

SP - 858

EP - 860

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 11

ER -